Why the study?
Does the addition of dantrolene or bromocriptine reduce the time to clinical response in patients with neuroleptic malignant syndrome?
Population
67 patients with neuroleptic malignant syndrome
Comparison
Dantrolene or bromocriptine added to… vs Supportive measures alone
Design
Systematic_review
Authors
Loading...
Supports adding dantrolene or bromocriptine to supportive care for faster NMS recovery; confirms benefit in Level 1 evidence synthesis.
Does the addition of dantrolene or bromocriptine reduce the time to clinical response in patients with neuroleptic malignant syndrome?
The addition of dantrolene or bromocriptine to supportive care significantly accelerates clinical recovery in patients with neuroleptic malignant syndrome.
Meir Rosenberg (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: